Medicare Enrolled
Dr. Jennifer Difalco, M.D.
Family Medicine · Brockton, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Difalco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Difalco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Difalco
Dr. Jennifer Difalco is a family medicine specialist in Brockton, MA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Difalco performed 809 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Difalco received a total of $8,841 from 66 pharmaceutical and/or device companies across 496 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Difalco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 33% volume in MA
$8,841 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗809
Medicare services
Top 33% in MA for family medicine
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
154 | $58 | $248 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
98 | $13 | $45 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
92 | $8 | $30 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
83 | $9 | $66 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
79 | $132 | $163 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $80 | $326 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
70 | $4 | $12 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
64 | $16 | $46 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
30 | $10 | $24 |
| Annual depression screening | 29 | $19 | $29 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
18 | $41 | $90 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
17 | $46 | $49 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,841
Total received (2018-2024)
Avg $1,263/year across 7 years
Top 3% in MA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
496
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,626
2023
$1,366
2022
$446
2021
$1,248
2020
$751
2019
$2,149
2018
$1,254
Payments by company (2024)
ABBVIE INC.
$288
Lilly USA, LLC
$271
PFIZER INC.
$213
Novartis Pharmaceuticals Corporation
$166
Novo Nordisk Inc
$128
Esperion Therapeutics, Inc.
$82
SHIELD THERAPEUTICS INC
$81
Exact Sciences Corporation
$43
Merck Sharp & Dohme LLC
$39
SANOFI PASTEUR INC.
$38
Amgen Inc.
$34
Kowa Pharmaceuticals America, Inc.
$32
ANI Pharmaceuticals, Inc.
$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Antares Pharma, Inc.
$22
Phathom Pharmaceuticals, Inc.
$21
Abbott Laboratories
$21
AstraZeneca Pharmaceuticals LP
$21
E.R. Squibb & Sons, L.L.C.
$17
Seqirus USA Inc
$16
Lucid Diagnostics Inc.
$14
IDORSIA PHARMACEUTICALS US INC
$14
Tolmar, Inc.
$13
Top 3 companies account for 47.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,208
Lilly USA, LLC
$673
Tosoh Bioscience, Inc.
$558
AbbVie Inc.
$411
Novartis Pharmaceuticals Corporation
$383
Novo Nordisk Inc
$372
Amgen Inc.
$358
ABBVIE INC.
$347
Biohaven Pharmaceuticals, Inc.
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$216
Merck Sharp & Dohme Corporation
$214
Kowa Pharmaceuticals America, Inc.
$203
Eisai Inc.
$197
GlaxoSmithKline, LLC.
$191
Allergan Inc.
$185
Antares Pharma, Inc.
$181
Janssen Pharmaceuticals, Inc
$179
Esperion Therapeutics, Inc.
$166
Amarin Pharma Inc.
$150
E.R. Squibb & Sons, L.L.C.
$130
Merck Sharp & Dohme LLC
$123
AbbVie, Inc.
$122
Abbott Laboratories
$120
Takeda Pharmaceuticals U.S.A., Inc.
$114
TherapeuticsMD, Inc.
$110
Exact Sciences Corporation
$103
Regeneron Healthcare Solutions, Inc.
$97
IDORSIA PHARMACEUTICALS US INC
$83
SHIELD THERAPEUTICS INC
$81
AstraZeneca Pharmaceuticals LP
$79
SANOFI PASTEUR INC.
$69
Astellas Pharma US Inc
$68
Vanda Pharmaceuticals Inc.
$68
West-Ward Pharmaceuticals
$64
SANOFI-AVENTIS U.S. LLC
$63
Teva Pharmaceuticals USA, Inc.
$61
Axsome Therapeutics, Inc.
$53
Medicines360
$50
Allergan, Inc.
$46
IBSA Pharma Inc.
$46
Acerus Pharmaceuticals Corporation
$44
Tolmar, Inc.
$43
Shire North American Group Inc
$43
Shield Therapeutics Inc
$39
Lupin Inc.
$38
Otsuka America Pharmaceutical, Inc.
$38
Hologic, LLC
$31
ANI Pharmaceuticals, Inc.
$29
Biohaven Pharmaceutical Holding Company Ltd.
$29
Scilex Pharmaceuticals Inc.
$26
Hikma Pharmaceuticals USA
$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Phathom Pharmaceuticals, Inc.
$21
Supernus Pharmaceuticals, Inc.
$21
TerSera Therapeutics LLC
$20
Alexion Pharmaceuticals, Inc.
$20
Paratek Pharmaceuticals, Inc.
$18
Seqirus USA Inc
$16
Endo Pharmaceuticals Inc.
$16
Boston Scientific Corporation
$16
Lucid Diagnostics Inc.
$14
Avanir Pharmaceuticals, Inc.
$14
Xeris Pharmaceuticals, Inc.
$13
Genentech USA, Inc.
$12
Medicure Pharma Inc.
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 27.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ANNOVERA · ANORO ELLIPTA · Aimovig · Aptima HSV · Aptima Trich · BEYFORTUS · BRILINTA · BYSTOLIC · CHANTIX · COMIRNATY · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flucelvax · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GVOKE PFS · HETLIOZ · IMVEXXY · JANUVIA · JARDIANCE · JATENZO · LEQVIO · LINZESS · LYRICA · Liletta · Livalo · MOUNJARO · Mitigare · NASCOBAL · NEXLETOL · NOCDURNA · NUEDEXTA · NURTEC ODT · NUZYRA · Natesto · OFEV · OTREXUP · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolia · QMIIZ ODT · QULIPTA · QUVIVIQ · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLOSEC · ST AIA-PACK · STIOLTO RESPIMAT · STRENSIQ · SUPRAX · SYMBICORT · SYNTHROID · Saxenda · Sunosi · Synthroid · TLANDO · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRUMENBA · TSH · Tirosint · Tresiba · Trintellix · UBRELVY · VAXELIS · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · ZEPBOUND · ZORYVE · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · ZYPITAMAG (pitavastatin)
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
1,048
County median income
$109,698
Nearest hospital to ZIP centroid (approximate)
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Difalco is a clinical cardiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Difalco experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Difalco performed 154 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Difalco receive payments from pharmaceutical companies?
Yes. Dr. Difalco received a total of $8,841 from 66 companies across 496 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Difalco's costs compare to other family medicine physicians in Brockton?
Dr. Difalco's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Difalco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Brockton
Browse family medicine physicians in Brockton ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in MA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in MA
Which MA family medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Tosoh Bioscience, Inc. Payments to Doctors
See all physicians who received payments from Tosoh Bioscience, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology